Tone mix
Week by week 52 weeks
Share of Fate Therapeutics, Inc.'s 99 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Apr 14, 2025 · tone +100Fate Therapeutics, Inc. Receives Regenerative Medicine Advanced Therapy Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus+94
- Week of Jun 8, 2026 · tone +100H.C. Reiterates "Buy" Rating On Fate Therapeutics (FATE) With $7 PT+80
- Week of Mar 10, 2025 · tone -66Stock Analysts' Downgrades for March 11th (ACU, AFYA, ARVN, CSV, FATE, FNV, FRPT, GPRE, IMAX, INBK)-60
- Week of Sep 21, 2026 · tone +100Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN+58
- Week of Aug 17, 2026 · tone +100Wedbush Reaffirms "Outperform" Rating for Fate Therapeutics (NASDAQ:FATE)+55
- Week of Jul 14, 2025 · tone +77Fate Therapeutics, Inc. (FATE) Reaffirmed at Neutral After EULAR Data+51
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Fate Therapeutics, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | 0 |
| Last 30 sessions | 14 | +7 |
| Last 90 sessions | 30 | +23 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletFate Therapeutics, Inc. (NASDAQ:FATE) Stock Has Average Target Price of $5.90Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Fate Therapeutics, Inc. (NASDAQ:FATE) Stock Has Average Target Price of $5.90 | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletFate Therapeutics Reports Third Quarter 2026 Financial Results and Business UpdatesNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Fate Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.manilatimes.net · 1 outletFate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026Neutral
- www.themarketsdaily.com · 1 outletHead to Head Survey: Applied Therapeutics (NASDAQ:APLT) vs. Fate Therapeutics (NASDAQ:FATE)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026 | www.manilatimes.net | 1 | Neutral |
| Head to Head Survey: Applied Therapeutics (NASDAQ:APLT) vs. Fate Therapeutics (NASDAQ:FATE) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletAnalyzing Fate Therapeutics (NASDAQ:FATE) & Applied Therapeutics (NASDAQ:APLT)Neutral
- www.tickerreport.com · 1 outletComparing Fate Therapeutics (NASDAQ:FATE) and Applied Therapeutics (NASDAQ:APLT)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Analyzing Fate Therapeutics (NASDAQ:FATE) & Applied Therapeutics (NASDAQ:APLT) | www.dailypolitical.com | 1 | Neutral |
| Comparing Fate Therapeutics (NASDAQ:FATE) and Applied Therapeutics (NASDAQ:APLT) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletFate Therapeutics Taps Jamie Harrell To Guide Commercial Strategy For FT819 And FT839Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Fate Therapeutics Taps Jamie Harrell To Guide Commercial Strategy For FT819 And FT839 | www.rttnews.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Fate Therapeutics, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.